SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Zwiener who wrote (654)10/16/1997 3:40:00 PM
From: David Bleich   of 1115
 
Hi everyone:

I am new to this forum, but with significant expertise in immunology and intracellular signaling. This biotech company looks like it may have some potential, but there is competition in this field. Take a look at avax-tech.com. They too have a melanoma vaccine with an interesting platform. AVAX conjugates dinitrophenol to melanoma antigens to render them immunogenic and also have ealy phase II data which shows promise. Does anyone know whether LIDAK has any corporate alliances? What is the burn-rate? How experienced is the management in drug dvelopment and FDA procedures? These factors will be key in LIDAK's success.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News